Skip to content
MedCompare

Lenvatinib

Also known as Lenvima (us), Lenvakast (india)

Cancer & Oncology
Save $14,697/mo
376× cheaper

Lenvatinib is used to treat a certain type of thyroid cancer that has returned or that has spread to other parts of the body and cannot be treated with radioactive iodine.

United States
$14,736
per month
India
$39
per month
You save
$14,697
99.73% cheaper in India
37.1K US scripts/yr$545.8M potential annual savings$547.3M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC21H19ClN4O4

SMILES: COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl

Compare the price
US price$14,736per month
India price$39per month
You save$14,69799.73% less

Based on 30 units per month. US $491.21 vs India $1.31 per unit.

Total over 1 periodSave $14,697$14,736 → $39
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$88,183
Estimated travel cost
− $2,300
Net savings after travel
$85,883

Even after travel, you could come out ahead by about $85,883.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Lenvatinib is filled about 37.1K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$547.3M
If sourced from India
$1.5M
Potential annual savings
$545.8M
−100%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.